Manufacturing

Daiichi Sankyo is building Japan's first mRNA plant

After submitting an application for approval of its mRNA COVID-19 vaccine candidate in its home country, Daiichi Sankyo is building a plant in Japan.

Kevin Dunleavy Feb 7, 2023 10:43am

Catalent reports weaker earnings, stronger ties with Moderna

Feb 7, 2023 9:40am

Catalent draws buyout interest from Danaher: Bloomberg

Feb 6, 2023 11:24am

Teva walks away from PhRMA after similar move by AbbVie

Feb 3, 2023 4:05pm

It's the end of the line for Medicago's plant-based COVID shot

Feb 3, 2023 10:44am

Lilly is taking a hard line with its buzzy diabetes med Mounjaro

Feb 2, 2023 11:18am